NCT02649790 2025-03-19Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsKaryopharm Therapeutics IncPhase 1/2 Completed277 enrolled
NCT00601172 2018-01-17A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.GlaxoSmithKlinePhase 3 Completed710 enrolled 29 charts